News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Motahari Saeed
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/23/2019 |
4
| Motahari Saeed (President & CEO) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 16,000 shares
@ $0
Granted 59,206 shares
@ $0
Granted 64,000 options to buy
@ $8.06, valued at
$515.8k
Granted 282,152 options to buy
@ $3.81, valued at
$1.1M
|
|
| 04/19/2019 |
4
| Motahari Saeed (President & CEO) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 16,000 shares
@ $0
Granted 59,206 shares
@ $0
Granted 64,000 options to buy
@ $8.06, valued at
$515.8k
Granted 282,152 options to buy
@ $3.81, valued at
$1.1M
|
|
| 04/17/2018 |
4
| Motahari Saeed (President & CEO) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 11,000 shares
@ $0
Disposed/sold 11,000 restricted stock units
@ $0 |
|
| 11/21/2017 |
4
| Motahari Saeed (President & CEO) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $5.37, valued at
$214.8k
|
|
| 08/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/20/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|